These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24410765

  • 1. Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
    Hirakawa H, Yokoyama Y, Yoshida H, Mizunuma H.
    J Ovarian Res; 2014 Jan 10; 7():4. PubMed ID: 24410765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aromatase and breast cancer.
    Brodie A, Sabnis G, Jelovac D.
    J Steroid Biochem Mol Biol; 2006 Dec 10; 102(1-5):97-102. PubMed ID: 17113978
    [Abstract] [Full Text] [Related]

  • 7. Aromatase inhibitors and xenograft studies.
    Chumsri S, Sabnis GJ, Howes T, Brodie AM.
    Steroids; 2011 Jul 10; 76(8):730-5. PubMed ID: 21420993
    [Abstract] [Full Text] [Related]

  • 8. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y, Xin B, Shigeto T, Mizunuma H.
    J Cancer Res Clin Oncol; 2011 Aug 10; 137(8):1219-28. PubMed ID: 21681689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stopping treatment can reverse acquired resistance to letrozole.
    Sabnis GJ, Macedo LF, Goloubeva O, Schayowitz A, Brodie AM.
    Cancer Res; 2008 Jun 15; 68(12):4518-24. PubMed ID: 18559495
    [Abstract] [Full Text] [Related]

  • 13. Aromatase expression in ovarian epithelial cancers.
    Cunat S, Rabenoelina F, Daurès JP, Katsaros D, Sasano H, Miller WR, Maudelonde T, Pujol P.
    J Steroid Biochem Mol Biol; 2005 Jan 15; 93(1):15-24. PubMed ID: 15748828
    [Abstract] [Full Text] [Related]

  • 14. Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.
    Sabnis GJ, Goloubeva O, Chumsri S, Nguyen N, Sukumar S, Brodie AM.
    Cancer Res; 2011 Mar 01; 71(5):1893-903. PubMed ID: 21245100
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I, Itoh T, Chen S.
    J Steroid Biochem Mol Biol; 2005 Dec 01; 97(4):360-8. PubMed ID: 16263272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
    Wang J, Gildea JJ, Yue W.
    Oncogene; 2013 Oct 31; 32(44):5233-40. PubMed ID: 23178495
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
    Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, Albertelli MA, Feldman D.
    Horm Cancer; 2011 Jun 31; 2(3):190-202. PubMed ID: 21686077
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.